Skip to content
Inciteful Med

Survivorship, Relapse & Monitoring

Last updated:

Remission in Granulomatosis with polyangiitis (GPA) requires lifelong monitoring to detect relapses early. While flares are common, regular lab tests for kidney function and inflammation allow your multidisciplinary care team to catch and treat them before major organ damage occurs.

Key Takeaways

  • • Relapses are common in GPA, but regular monitoring allows doctors to catch and treat them early before significant organ damage occurs.
  • • Patients with the PR3-ANCA serotype generally have a higher risk of relapse than those with MPO-ANCA.
  • • Long-term monitoring requires regular checks of kidney function, inflammatory markers, ANCA titers, and specific organs like the lungs and sinuses.
  • • Managing GPA requires a multidisciplinary medical team led by a rheumatologist, alongside specialists like nephrologists and pulmonologists.
  • • Maintenance treatments for GPA suppress the immune system, making proactive infection prevention and vaccination crucial for long-term health.

Entering remission is a major milestone in your journey with Granulomatosis with polyangiitis (GPA). However, because GPA is a chronic condition, the focus of your care shifts from “curing” the disease to “guarding” against its return [1][2].

Understanding the Risk of Relapse

A relapse (or “flare”) occurs when the immune system becomes overactive again [2]. Relapse is common in GPA, with rates historically approaching 60% by the five-year mark [3]. Do not let this number panic you. Because of regular monitoring, relapses are now usually caught very early—long before they cause major organ damage [4][2]. A relapse is often treated much more easily than the initial diagnosis, typically by adjusting your maintenance medication [4].

Your specific ANCA serotype helps predict this risk. Patients who test positive for PR3-ANCA have a higher risk of relapse compared to those with MPO-ANCA [2][5].

Your Long-Term Monitoring Toolkit

To stay one step ahead, your care team will use several tools [2][4]:

  1. Kidney Function: Regular tests for creatinine and urinalysis (to check for microscopic blood or protein) are essential, as kidney inflammation often has no physical symptoms [2][6].
  2. Inflammatory Markers: Tests like CRP (C-reactive protein) and ESR (sedimentation rate) measure general inflammation [4].
  3. ANCA Titers: Checking the level of antibodies in your blood can provide clues, but a rising ANCA alone does not guarantee a flare [2][4].
  4. Organ-Specific Checks: Regular lung CT scans or visits to an ENT specialist to check for airway narrowing [2][7][8].

Managing Long-Term Risks and Daily Living

Living with GPA and its treatments involves managing certain long-term risks [4]:

  • Infections: Maintenance medications suppress your immune system [3][4]. It is strongly recommended to stay up-to-date on vaccinations (like flu and pneumonia), wear a high-quality mask in crowded indoor spaces, and report fevers to your doctor immediately [3].
  • Blood Clots: Patients with GPA have an increased risk of venous thromboembolism (VTE), or blood clots, especially during periods when the disease is active [9][10].
  • Lifestyle: While no specific “GPA diet” exists, maintaining a heart-healthy, low-sodium diet helps manage the weight gain and blood pressure issues often caused by steroids. Regular, gentle exercise helps combat fatigue and preserves bone density [4].
  • The Psychological Toll: Chronic monitoring can lead to “scanxiety” or a constant fear of relapse [11][3]. Acknowledging this emotional burden is a key part of long-term survivorship.

The Importance of a Multidisciplinary Team

GPA is a systemic disease, meaning you need a “team of rivals”—specialists who work together [2][4]:

  • Rheumatologist: The “quarterback” of your care, managing your immunosuppressants [2].
  • Nephrologist: Focuses on protecting your kidney function [2][6].
  • Pulmonologist: Monitors your lung health and breathing [2].
  • ENT Surgeon: Manages issues in the sinuses, ears, and windpipe [8].
  • Ophthalmologist & Dermatologist: Crucial for monitoring atypical disease presentations like eye inflammation or skin lesions [12][13].

Frequently Asked Questions

What is a GPA relapse?
A relapse, or flare, happens when the immune system becomes overactive again after a period of remission. With regular monitoring, these are usually caught and treated by adjusting medication early, before causing major organ damage.
How does my ANCA serotype affect my risk of a GPA flare?
Your specific ANCA serotype helps predict your relapse risk. Patients who test positive for PR3-ANCA generally have a higher risk of experiencing a flare compared to those with MPO-ANCA.
What tests are used to monitor GPA during remission?
Your care team will use blood tests for inflammatory markers like CRP and ESR, check your ANCA titers, and monitor kidney function through creatinine and urinalysis. They may also use CT scans or specialist exams to check specific organs like your lungs and sinuses.
Who should be on my care team for Granulomatosis with polyangiitis?
Because GPA affects multiple body systems, you need a multidisciplinary team. This typically includes a rheumatologist to manage medications, alongside specialists like a nephrologist for kidneys, a pulmonologist for lungs, and an ENT for sinus and airway issues.
What are the long-term health risks of living with GPA?
Maintenance medications suppress your immune system, which increases your risk of infections. Patients also have a higher risk of developing blood clots, especially when the disease is active, so proactive prevention and monitoring are critical.

Questions for Your Doctor

  • • What is my specific ANCA serotype (PR3 or MPO), and how does that affect my personal risk of a relapse?
  • • Which member of my multidisciplinary team—the rheumatologist, nephrologist, or pulmonologist—is the 'point person' I should call first if I notice a new symptom?
  • • What specific trends in my lab results (like a rising CRP or a change in my ANCA titer) would make you concerned about a flare-up?
  • • How often should I have my kidney function tested, and what is the best way for me to monitor for blood in my urine at home?
  • • What preventative steps should I take to reduce my risk of infections or blood clots while on maintenance therapy?

Questions for You

  • • Do I have a 'flare plan' in place so I know exactly what symptoms to report immediately?
  • • How am I managing the stress and anxiety that comes with long-term medical monitoring?
  • • Am I keeping a 'symptom diary' to help my doctors distinguish between a true relapse and a side effect of my medication?
  • • Who is in my personal support system that I can lean on during periods of uncertainty?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    ANCA-associated vasculitis with renal involvement.

    Binda V, Moroni G, Messa P

    Journal of nephrology 2018; (31(2)):197-208 doi:10.1007/s40620-017-0412-z.

    PMID: 28560688
  2. 2

    Granulomatosis with Polyangiitis: Recurrence or Treatment Consequences?

    Diegues A, Tavares J, Sá D, et al.

    European journal of case reports in internal medicine 2021; (8(4)):002448 doi:10.12890/2021_002448.

    PMID: 33987124
  3. 3

    Relapsing granulomatosis with polyangiitis with severe lung and upper respiratory tract involvement successfully treated with rituximab.

    Masiak A, Zdrojewski Z

    Reumatologia 2017; (55(4)):208-212 doi:10.5114/reum.2017.69783.

    PMID: 29056777
  4. 4

    ANCA-Associated Vasculitic Neuropathies: A Review.

    Koike H, Nishi R, Ohyama K, et al.

    Neurology and therapy 2022; (11(1)):21-38 doi:10.1007/s40120-021-00315-7.

    PMID: 35044596
  5. 5

    Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive and ANCA-Negative Patients With Granulomatosis With Polyangiitis (Wegener's): Distinct Patient Subsets.

    Miloslavsky EM, Lu N, Unizony S, et al.

    Arthritis & rheumatology (Hoboken, N.J.) 2016; (68(12)):2945-2952 doi:10.1002/art.39812.

    PMID: 27428559
  6. 6

    A Rare Case of Nephrotic-Range Proteinuria in Antineutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis.

    Nasr R, Balasubramanian P, Desiderio L, Abdelattif M

    Cureus 2022; (14(5)):e24889 doi:10.7759/cureus.24889.

    PMID: 35572457
  7. 7

    Granulomatosis with Polyangiitis: A Focus on Differences and Similarities Between Child and Adult Patients.

    Calabrese V, Gallizzi R, Spagnolo A, et al.

    Medicina (Kaunas, Lithuania) 2025; (61(3)) doi:10.3390/medicina61030534.

    PMID: 40142345
  8. 8

    Anti-Neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis Causes Aortic Valve Degeneration and Severe Aortic Regurgitation.

    Guterbaum TJ, Husic M, Voss A, Dahl JS

    The American journal of case reports 2019; (20()):423-429 doi:10.12659/AJCR.912693.

    PMID: 30930460
  9. 9

    High incidence of venous thromboembolism but not of coronary artery disease in granulomatosis with polyangiitis in first years after diagnosis.

    Borowiec A, Hadzik-Błaszczyk M, Kowalik I, et al.

    Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG 2019; (36(3)):202-208 doi:10.36141/svdld.v36i3.8088.

    PMID: 32476955
  10. 10

    Elevated levels of d-dimer are associated with inflammation and disease activity rather than risk of venous thromboembolism in patients with granulomatosis with polyangiitis in long term observation.

    Borowiec A, Dąbrowski R, Kowalik I, et al.

    Advances in medical sciences 2020; (65(1)):97-101 doi:10.1016/j.advms.2019.12.007.

    PMID: 31923773
  11. 11

    Life-threatening onset of systemic vasculitis requiring intensive care unit admission: a case series.

    Monti S, Montecucco C, Pieropan S, et al.

    Clinical and experimental rheumatology 2015; (33(2 Suppl 89)):S-126-31 doi:10.1136/annrheumdis-2015-eular.5151.

    PMID: 26016763
  12. 12

    Ocular manifestations in ANCA-associated vasculitis: a comprehensive analysis from Chinese medical centers.

    Liu S, Xu M, Zhao X, et al.

    Clinical rheumatology 2024; (43(9)):2899-2910 doi:10.1007/s10067-024-07034-y.

    PMID: 39002071
  13. 13

    A Rare Case of Granulomatosis With Polyangiitis With Cutaneous Pyoderma Gangrenosum-Like Lesions of the Bilateral Parotid Glands.

    Short SH, McGlone M, Ohlstein JF

    Ear, nose, & throat journal 2025; 1455613251345431 doi:10.1177/01455613251345431.

    PMID: 40658486

This page provides educational information on managing and monitoring Granulomatosis with polyangiitis (GPA). Always consult your rheumatologist or multidisciplinary care team before adjusting your maintenance therapy or flare plan.

Stay up to date

Get notified when new research about Granulomatosis with polyangiitis is published.

No spam. Unsubscribe anytime.